STOCK TITAN

CooperCompanies Announces Release Date for Fourth Quarter and Full Year 2026

CooperCompanies (Nasdaq: COO) will report its fourth-quarter and full-year 2026 financial results on December 3, 2026, at 4:15 PM ET.

(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags

CooperCompanies (Nasdaq: COO) will report its fourth-quarter and full-year 2026 financial results on December 3, 2026, at 4:15 PM ET.

A conference call at 5:00 PM ET will discuss the results and current corporate developments. A simultaneous audio webcast and subsequent replay will be available at www.investor.coopercos.com.

Loading...
Loading translation...

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

SAN RAMON, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, announced today it will report fourth quarter and full year 2026 financial results on Thursday, December 3, 2026, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments.

The dial-in number for the call is 800-715-9871 and the conference ID is 1193290. A simultaneous audio webcast and subsequent replay can be accessed at www.investor.coopercos.com

About CooperCompanies

CooperCompanies (Nasdaq: COO) is a leading global medical device company focused on helping people experience life’s beautiful moments through its two business units, CooperVision and CooperSurgical. CooperVision is a trusted leader in the contact lens industry, helping to improve the way people see each day. CooperSurgical is a leading fertility and women’s healthcare company dedicated to putting time on the side of women, babies, and families at the healthcare moments that matter most. Headquartered in San Ramon, CA, CooperCompanies has a workforce of more than 15,000, sells products in over 130 countries, and positively impacts over fifty million lives each year. For more information, please visit www.coopercos.com

Contact:

Kim Duncan 
Vice President, Investor Relations and Risk Management 
925-460-3663 
ir@cooperco.com


Keep reading